INPP5D and neoplasm: This effect is thought to take action by compromising anti-inflammatory signaling pathways such as Ship1, or through the suppression of SOCS1 cytokine signaling [45] and the targeted modulation of peculiar tumor suppressor genes in tumor-supporting stromal cells [46].